GILEAD SCIENCES, INC. Quarterly Other Assets, Noncurrent in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Gilead Sciences, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q1 2010 to Q3 2024.
  • Gilead Sciences, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $5.49B, a 30.8% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.49B +$1.29B +30.8% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $4.77B -$343M -6.71% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $5.19B +$236M +4.77% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $4.79B -$8M -0.17% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $4.2B -$418M -9.05% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $5.11B +$253M +5.21% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $4.95B -$174M -3.39% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $4.8B -$163M -3.28% Dec 31, 2022 10-K 2024-02-23
Q3 2022 $4.62B -$121M -2.55% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $4.86B -$692M -12.5% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $5.13B -$404M -7.31% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $4.96B -$745M -13.1% Dec 31, 2021 10-K 2023-02-22
Q3 2021 $4.74B -$1.27B -21.2% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $5.55B -$1.47B -20.9% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $5.53B -$1.55B -21.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $5.71B -$1.73B -23.3% Dec 31, 2020 10-K 2022-02-23
Q3 2020 $6.01B +$780M +14.9% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $7.02B +$4.11B +141% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $7.08B +$4.16B +142% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $7.44B +$4.88B +191% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $5.23B +$2.45B +87.7% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $2.91B +$305M +11.7% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $2.92B +$279M +10.6% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $2.56B -$167M -6.14% Dec 31, 2018 10-K 2020-02-25
Q3 2018 $2.79B +$176M +6.74% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $2.61B +$290M +12.5% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $2.64B +$330M +14.3% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $2.72B -$1.17B -30.1% Dec 31, 2017 10-K 2019-02-26
Q3 2017 $2.61B +$964M +58.5% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $2.32B +$838M +56.6% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $2.31B +$1.02B +78.7% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $3.9B +$2.96B +317% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $1.65B +$789M +92% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $1.48B +$799M +117% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 $1.29B +$711M +122% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $934M +$203M +27.8% Dec 31, 2015 10-K 2017-02-27
Q3 2015 $858M +$591M +221% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $682M +$469M +220% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 $583M +$379M +185% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 $731M +$212M +40.8% Dec 31, 2014 10-K 2016-02-24
Q3 2014 $267M +$128M +91.8% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $213M +$68.9M +47.8% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $204M +$54.5M +36.4% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $519M +$360M +226% Dec 31, 2013 10-K 2015-02-25
Q3 2013 $139M -$31.2M -18.3% Sep 30, 2013 10-Q 2013-10-31
Q2 2013 $144M -$27.3M -16% Jun 30, 2013 10-Q 2013-08-01
Q1 2013 $150M -$19.4M -11.4% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $159M -$1.49M -0.93% Dec 31, 2012 10-K 2014-02-25
Q3 2012 $171M +$39M +29.6% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 $171M +$51.9M +43.5% Jun 30, 2012 10-Q 2012-08-01
Q1 2012 $169M +$43.7M +34.8% Mar 31, 2012 10-Q 2012-05-04
Q4 2011 $161M -$20.5M -11.3% Dec 31, 2011 10-K 2013-02-27
Q3 2011 $132M +$19.7M +17.6% Sep 30, 2011 10-Q 2011-11-04
Q2 2011 $119M +$28M +30.7% Jun 30, 2011 10-Q 2011-08-05
Q1 2011 $126M +$28.1M +28.8% Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $181M Dec 31, 2010 10-K 2012-02-23
Q3 2010 $112M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $91.3M Jun 30, 2010 10-Q 2010-08-09
Q1 2010 $97.5M Mar 31, 2010 10-Q 2010-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.